Both experts in the field, one with an academic view and one from industry, they discuss what can be done today with protein design, new innovations coming in the next year or two, and how they think about improving selectivity and sensitivity. Plus, how AI is changing the field, what it takes to be differentiated, and implications of new startups sharing less knowledge than has been traditionally done. Chapters The current state of the art – 1:05 What is coming in the next y

Servier's 'Golden Ticket' gave Deck Bio a place to work at LabCentral and access to Servier's experts for advice. Jack and Irene discuss the benefits of this kind of support to a smaller company, and other ways more established players nurture the biotech ecosystem in hubs like Kendall Square. Chapters Intros - 0:07 Deck Bio - 1:25 The value of collaboration - 2:22 What Servier looks for in collaborators - 3:07 Jack's clinical background perspective - 6:06 Support from the La

In a wide-ranging discussion, Dr. Singh and Dr. Andtbacka reflect on the success of the immunotherapy field and the cancer centers that...

Yossef Baidi and Fang Xie describe how getting involved in the club has benefited them, and the idea behind their new podcast (George...

She discusses the report and specifics on NIH funding, VC investment, jobs, biotech clusters within Massachusetts, and more. VIEW THE...

They explain the size and depth of the cuts, and how it will affect research on both respiratory and non-respiratory conditions. Plus,...